Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	16.07	19.19	15.11	11.78	42.35
Cash & Short-Term Investments	16.07	19.19	15.11	11.78	42.35
Cash Growth	-16.28%	27.01%	28.26%	-72.18%	98.34%
Other Receivables	1.37	2.35	1.03	2.4	0
Total Trade Receivables	1.37	2.35	1.03	2.4	0
Other Current Assets	1.63	0.48	0.99	2.44	3.63
Total Current Assets	19.07	22.02	17.13	16.62	45.98
Net Property, Plant & Equipment	-	-	-	-	22.15
Other Long-Term Assets	-	-	-	17.8	-
Total Assets	19.07	22.02	17.13	34.42	68.14
Accounts Payable	1.3	1.75	1.75	2.52	11.13
Current Portion of Leases	-	-	-	-	0.62
Unearned Revenue	0.97	-	-	-	1.15
Other Current Liabilities	-	1.71	1.33	5.26	-
Total Current Liabilities	2.27	3.46	3.07	7.78	12.9
Long-Term Leases	-	-	-	-	11.25
Other Long-Term Liabilities	-	-	-	7.04	-
Total Long-Term Liabilities	-	-	-	7.04	11.25
Total Liabilities	2.27	3.46	3.07	14.82	24.15
Common Stock	0.02	0.01	0.01	0.01	0.01
Additional Paid-in Capital	475.96	465.56	450.33	447.64	442.1
Retained Earnings	-459.18	-447.02	-436.29	-428.05	-398.12
Shareholders' Equity	16.8	18.56	14.05	19.6	43.99
Total Liabilities & Equity	19.07	22.02	17.13	34.42	68.14
Total Debt	0	0	0	0	11.87
Net Cash (Debt)	16.07	19.19	15.11	11.78	30.48
Net Cash Growth	-16.28%	27.01%	28.26%	-61.35%	235.15%
Net Cash Per Share	1.05	2.14	1.72	1.41	3.98
Book Value	16.8	18.56	14.05	19.6	43.99
Book Value Per Share	1.10	2.07	1.60	2.35	5.75
Tangible Book Value	16.8	18.56	14.05	19.6	43.99
Tangible Book Value Per Share	1.10	2.07	1.60	2.35	5.75

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q